CD8A and neoplasm: Indeed coadministration of DNA vaccines encoding gDE7 and IL-10 receptors has been shown to halt tumor-induced immune suppressive cells (MDSC) and enhance strong tumor-specific CD8+ T-cell response leading to better control of tumors at advanced growth stages (37).